Healthcare research from Johnson & Johnson, page 28
A filtered view. Show the full list.
Refine
Listings
-
Clinical trial reportThe New England journal of medicine
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportThe New England journal of medicine
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleProceedings of the National Academy of Sciences of the United States of America
Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Disease researchAdded
-
ArticleCurrent medical research and opinion
Drivers and barriers to health-seeking behaviors and interactions: a qualitative study of Black patients with lung cancer and with peripheral artery disease
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Public healthAdded
-
ArticleCurrent medical research and opinion
Patient and caregiver insights into lung cancer treatment decision-making: an exploratory focus group
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleCurrent medical research and opinion
Real-world prevalence of potential drug-drug interactions associated with oral advanced therapies indicated for ulcerative colitis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportCurrent medical research and opinion
Assessment of patient-reported depression severity in subpopulation of ESCAPE-TRD study: esketamine nasal spray versus quetiapine extended release for treatment-resistant depression
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleCurrent medical research and opinion
Exacerbation and myasthenic crisis in generalized myasthenia gravis: real-world healthcare resource utilization and cost burden in the United States
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Public healthAdded
-
ArticleCurrent medical research and opinion
Differences in treatment decision-making for non-small cell lung cancer among patients and physicians, by race and ethnicity
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Public healthAdded
-
ArticleLeukemia & lymphoma
Treatment-emergent peripheral neuropathy associated with bortezomib-based frontline regimens for multiple myeloma
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of biopharmaceutical statistics
Joint modeling of longitudinal endpoints and its applications to trial planning, monitoring and analysis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Research dataAdded
-
LetterDrug delivery
Letter to the Editor regarding 'Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study'
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of medical economics
Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of medical economics
Healthcare resource utilization and costs among patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide in the United States (2019-2023)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of medical economics
Net present value cost analysis for treating retinitis pigmentosa
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleOphthalmic genetics
Social media-derived patient perspectives on the burden of inherited retinal diseases, including retinitis pigmentosa
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleOphthalmic genetics
The timing of genetic testing and healthcare costs associated with the diagnostic journey of inherited retinal disease
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleFuture oncology (London, England)
Burden of illness among patients with relapsed or refractory multiple myeloma, and eligible for B-cell maturation antigen-targeted therapies
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Public healthAdded
-
ArticleFuture oncology (London, England)
Community hematologist/oncologist perspectives on minimal residual disease testing in patients with multiple myeloma
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleFuture oncology (London, England)
Fixed-duration ibrutinib-venetoclax for first-line treatment of patients with chronic lymphocytic leukemia: the REALITY-WW prospective real-world study cohort
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleBioanalysis
2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation (PART 3A - Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance PART 3B - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source
-
ArticleBioanalysis
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bioanalysis by Multiple Platforms; Super Sensitive ADA/NAb LBA (PART 2A - Recommendations on Advanced Strategies for Biomarkers, IVD/CDx Assays (BAV), Cell Based Assays (CBA), and Ligand-Binding Assays (LBA) PART 2B - Regulatory Agencies' Input on Biomarkers, IVD/CDx, and Biomarker Assay Validation)
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source
-
ArticleBioanalysis
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry (Part 1A - Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV)
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source
-
ArticleBioanalysis
Simultaneous quantification of siRNA antisense and sense strands by hybrid liquid chromatography-mass spectrometry
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source